Rajiv Patni's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Rajiv Patni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 27,000 | 27,000 | - | - | Director Stock Option (Right to Buy) | |
| BioXcel Therapeutics Inc | Rajiv Patni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Rajiv Patni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 13,500 | 13,500 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Patni Rajiv | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 54,000 | 54,000 | - | - | Employee Stock Option (right to buy) |